Author:
Moreira Fabrício A.,de Oliveira Antônio C.P.,Santos Victor R.,Moraes Márcio F.D.
Funder
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Fundação de Amparo à Pesquisa do Estado de Minas Gerais
Reference48 articles.
1. Disease-modifying effects of cannabidiol, β-caryophyllene and their combination in Syn1-Cre/Scn1aWT/A1783V mice, a preclinical model of Dravet syndrome;Alonso;Neuropharmacology,2023
2. Exploiting cannabinoid and vanilloid mechanisms for epilepsy treatment;Asth;Epilepsy & Behavior: E&B,2019
3. Behavioral and molecular effects induced by cannabidiol and valproate administration in the GASH/Sal model of acute audiogenic seizures;Cabral-Pereira;Frontiers in Behavioral Neuroscience,2020
4. Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders;Campos;Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences,2012
5. Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD. (2003). Drugs in R&D, 4(5), 306–309.